同和藥業(300636.SZ):控股股東豐隆實業、實控人樑忠誠擬合計減持不超277萬股
格隆匯 8 月 6日丨同和藥業(300636.SZ)公佈,控股股東之一豐隆實業有限公司(以下簡稱“豐隆實業”)計劃通過大宗交易或集中競價交易方式減持公司股份不超過2,572,398股(即不超過公告日公司總股本的2%,不超過豐隆實業及其一致行動人合計控制公司股份的4.8547%)。其中,通過大宗交易方式進行減持的,將於減持預披露公告披露之日起3個交易日之後的6個月內(即2020年8月12日至2021年2月11日)進行,且任意連續90個自然日內減持股份的總數不超過公司總股本的2%;通過集中競價交易方式進行減持的,將於減持預披露公告披露之日起15個交易日之後的6個月內(即2020年8月28日至2021年2月27日)進行,且任意連續90個自然日內減持股份的總數不超過公司總股本的1%。
公司實際控制人之一樑忠誠計劃通過大宗交易或集中競價交易方式減持公司股份不超過197,640股(即不超過公告日公司總股本的0.1537%,不超過其所持有公司股份的25%)。其中,通過大宗交易方式進行減持的,將於其減持預披露公告披露之日起3個交易日之後的6個月內(即2020年8月12日至2021年2月11日)進行,且任意連續90個自然日內減持股份的總數不超過公司總股本的2%;通過集中競價交易方式進行減持的,將於其減持預披露公告披露之日起15個交易日之後的6個月內(即2020年8月28日至2021年2月27日)進行,且任意連續90個自然日內減持股份的總數不超過公司總股本的1%。(此期間如遇法律、法規規定的股票買賣敏感期則不減持。)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.